IguanaBio has partnered with Biovays, an innovative biotechnology CRO pioneering biomarker-based drug discovery and lead identification. For a limited time, Biovays is offering a ten percent (10%) rebate for new customers and contracts. This is a one-time offer and available exclusively for IguanaBio Daily Newsletter Subscribers only.

Click here to learn how IguanaBio readers can save $ thousands…

About Biovays

Biovays is a premier biotechnology CRO that uses the expression, localization and quantification of biomarkers for optimal drug discovery. With state-of-the-art technology and expertise in molecular imaging, Biovays offers powerful analytical tools to several industries – opening up new possibilities for the screening of drug candidates.

Biovays‘ provides flexible, fully customized services within the constraints of the project environment – meeting client demands for accuracy, timeliness and cutting-edge research.

Via tailor-made protocols and a range of highly specialized models, Biovays helps clients leverage benefits and focus on their core business. From target discovery through to FDA approval, their innovative quantitative biomarker analysis streamlines drug development and boosts drug approval success rates.

For more information, please visit Biovays, and don’t forget to mention you found them on IguanaBio.

Related Posts